Triple Analysis: Apoptosis, Protein Kinase Inhibitors and AntibodiesBioSeeker Group ABNovember 1, 2012 6918 Pages - SKU: BIOS4910001 |
|
CompetitiveWatch Infectious Disease Testing: Strategic Profiles of Leading Suppliers
5/14/2013 | published by: Venture Planning Group
This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography
|
read more...
|
$3,500.00
|
|
Analytical Tool - Apoptosis in Oncology
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same
|
read more...
|
$11,625.00
|
|
Analytical Tool - Antibodies and Peptides in Oncology
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool – Antibodies and Peptides in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug
|
read more...
|
$22,312.50
|
|
Analytical Tool - Cancer Immunotherapy
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool- Cancer Immunotherapy offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at the same time a
|
read more...
|
$20,437.50
|
|
Analytical Tool - Cancer Therapeutic Antibodies
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool - Cancer Therapeutic Antibodies offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. It is at the same
|
read more...
|
$14,808.75
|
|
Antibodies in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Antibodies in Oncology Drug Pipeline Update 2013
The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of
|
read more...
|
$5,621.25
|
|
Monoclonal Antibody Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for monoclonal antibody has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends,
|
read more...
|
$2,000.00
|
|
Cancer Monoclonal Antibody Partnering Agreements - CP22012 - May2013v3
5/1/2013 | published by: Current Partnering
The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in
|
read more...
|
$1,995.00
|
|
Antibody Partnering Agreements - CP2113 - May2013v3
5/1/2013 | published by: Current Partnering
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides
|
read more...
|
$2,995.00
|
|
2013 Analysis of the Pap Smear/HPV Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/17/2013 | published by: Venture Planning Group
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of
|
read more...
|
$4,350.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Antibody Technologies Reports
- Monoclonal Antibody Markets in China
- Analytical Tool - Antibodies and Peptides in Oncology
- Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
- Ion Channel Modulators
- Antibody Technologies and Attrition Rates – an industry analysis 2013
